These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 15385232)

  • 1. Reboxetine in cocaine withdrawal treatment: a three cases report.
    Farina B; di Giannantonio M
    Drug Alcohol Rev; 2003 Sep; 22(3):373-4. PubMed ID: 15385232
    [No Abstract]   [Full Text] [Related]  

  • 2. Monotherapy with reboxetine in amphetamine withdrawal syndrome.
    Molina JD; de Pablo S; López-Muñoz F; Alamo C; Blasco-Fontecilla H; González-Parra S
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Sep; 30(7):1353-5. PubMed ID: 16631296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reboxetine may be helpful in the treatment of amphetamine withdrawal.
    Cox D; Bowers R; McBride A
    Br J Clin Pharmacol; 2004 Jul; 58(1):100-1. PubMed ID: 15207001
    [No Abstract]   [Full Text] [Related]  

  • 4. Reboxetine for the treatment of patients with Cocaine Dependence Disorder.
    Szerman N; Peris L; Mesías B; Colis P; Rosa J; Prieto A;
    Hum Psychopharmacol; 2005 Apr; 20(3):189-92. PubMed ID: 15799010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An open clinical trial of reboxetine in the treatment of social phobia.
    Atmaca M; Tezcan E; Kuloglu M
    J Clin Psychopharmacol; 2003 Aug; 23(4):417-9. PubMed ID: 12920422
    [No Abstract]   [Full Text] [Related]  

  • 6. Parthenolide prevents the expression of cocaine-induced withdrawal behavior in planarians.
    Rowlands AL; Pagán OR
    Eur J Pharmacol; 2008 Mar; 583(1):170-2. PubMed ID: 18275955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Escitalopram/reboxetine combination in depressed patients with substance use disorder.
    Camarasa X; Lopez-Martinez E; Duboc A; Khazaal Y; Zullino DF
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jan; 29(1):165-8. PubMed ID: 15610962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amantadine in the treatment of cocaine withdrawal.
    Thompson DF
    Ann Pharmacother; 1992; 26(7-8):933-4. PubMed ID: 1504406
    [No Abstract]   [Full Text] [Related]  

  • 9. A pilot trial of amantadine for ambulatory withdrawal for cocaine dependence.
    Morgan C; Kosten T; Gawin F; Kleber H
    NIDA Res Monogr; 1988; 81():81-5. PubMed ID: 3136395
    [No Abstract]   [Full Text] [Related]  

  • 10. Superior safety of reboxetine over amitryptiline in the elderly.
    Agelink MW; Ullrich H; Passenberg P; Sayar K; Brockmeyer NH
    Eur J Med Res; 2002 Sep; 7(9):415-6. PubMed ID: 12435620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reboxetine: a novel antidepressant.
    Kadhe NG; Chillar AJ; Deshmukh YA
    J Postgrad Med; 2003; 49(4):373-5. PubMed ID: 14699244
    [No Abstract]   [Full Text] [Related]  

  • 12. Sleepwalking associated with reboxetine in a young female patient with major depression--a case report.
    Künzel HE; Schuld A; Pollmächer T
    Pharmacopsychiatry; 2004 Nov; 37(6):307-8. PubMed ID: 15551201
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of efficacy and tolerability of reboxetine and venlafaxine XR in major depression and major depression with anxiety features: an open label study.
    Akkaya C; Sivrioglu EY; Akgoz S; Eker SS; Kirli S
    Hum Psychopharmacol; 2006 Jul; 21(5):337-45. PubMed ID: 16856215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute myocardial infarction associated with cocaine withdrawal.
    Levine MA; Nishikawa J
    CMAJ; 1991 May; 144(9):1139-40. PubMed ID: 2018966
    [No Abstract]   [Full Text] [Related]  

  • 15. A double-blind, placebo-controlled trial of amantadine, propranolol, and their combination for the treatment of cocaine dependence in patients with severe cocaine withdrawal symptoms.
    Kampman KM; Dackis C; Lynch KG; Pettinati H; Tirado C; Gariti P; Sparkman T; Atzram M; O'Brien CP
    Drug Alcohol Depend; 2006 Nov; 85(2):129-37. PubMed ID: 16697124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reboxetine addition in patients with mirtazapine-resistant depression: a case series.
    López-Muñoz F; Rubio G; Alamo C; García-García P; Pardo A
    Clin Neuropharmacol; 2006; 29(4):192-6. PubMed ID: 16855420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Important forms of depression. A report of experiences from the practice for the practice. (II)].
    Zink CD
    Med Welt; 1979 Oct; 30(42):1553-6. PubMed ID: 43452
    [No Abstract]   [Full Text] [Related]  

  • 18. An evaluation of efficacy and safety of reboxetine in elderly patients affected by "retarded" post-stroke depression. A random, placebo-controlled study.
    Rampello L; Alvano A; Chiechio S; Raffaele R; Vecchio I; Malaguarnera M
    Arch Gerontol Geriatr; 2005; 40(3):275-85. PubMed ID: 15814161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are antidepressants addictive?
    Dean AJ
    Drug Alcohol Rev; 2002 Dec; 21(4):317-9. PubMed ID: 12537699
    [No Abstract]   [Full Text] [Related]  

  • 20. Desipramine in the treatment of hypersomnolence following abrupt cessation of cocaine use.
    Baxter LR
    Am J Psychiatry; 1983 Nov; 140(11):1525-6. PubMed ID: 6625009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.